Interferon-beta Theraphy in Multiple Sclerosis Patients: is Response Age Dependent?

Kurne A., Terzi M., Aydin O. F., Onar M. K., Karabudak R.

JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, cilt.26, sa.2, ss.131-138, 2009 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 2
  • Basım Tarihi: 2009
  • Dergi Adı: JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.131-138
  • Anahtar Kelimeler: Multiple sclerosis, interferon beta, treatment response, age, prognosis, LATE-ONSET, NATURAL-HISTORY, MULTIVARIATE-ANALYSIS, PREDICTIVE FACTORS, OLD RATS, DISABILITY, PROGRESSION, REMYELINATION, DEMYELINATION, FEATURES
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

The onset of Multiple sclerosis (MS) is usually between 20 and 40 years and in those patients, beta-interferons reduce relapse frequency in a rate of 30%. The purpose of this study was to compare the therapeutical response to IFN beta in young versus older MS patients.